All companies
Visit website
Healthycell
OperatingLife Science Institute LLC
Healthcare · Founded 2012
Products use MICROGEL technology to deliver nutrients you can absorb in a pill free experience
Post-money valuation ⓘ
$15.7M
As of Jan 2022 · from Healthycell Stock 1 · pre-money + amount raised, not a traded price
Total raised
$251,765
Across 1 round since 2021
Latest share price
$0.29
Healthycell Stock 1 offering price
Financials
FY2019–FY2025 · from SEC filings · hover any figure for its source$1.3M
−$1.1M
2019
$2.1M
−$792K
2020
$2.3M
−$1.7M
2021
$5.6M
−$1.4M
2022
$7.6M
−$2.0M
2023
$10.0M
−$573K
2024
$11.6M
−$1.3M
2025
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Income statement
Revenue
$1,348,351
$2,080,600
$2,297,746
$5,647,592
$7,606,409
$9,988,255
$11,599,761
Cost of goods sold
$532,843
$926,886
$805,911
$1,859,293
$2,448,039
$2,852,070
$3,292,185
Gross margin
60%
55%
65%
67%
68%
71%
72%
Net income
-$1,125,576
-$792,178
-$1,713,836
-$1,402,751
-$2,003,706
-$572,757
-$1,273,981
Taxes paid
$0
$0
$0
$0
$0
-$0
$0
Balance sheet
Cash
$218,142
$59,164
$352,752
$1,653,471
$445,232
$654,083
$1,109,392
Accounts receivable
$15,453
$21,323
$86,968
$133,769
$202,598
$0
$187,689
Total assets
$1,288,903
$1,199,823
$2,219,126
$4,131,353
$2,633,466
$2,756,028
$4,074,043
Short-term debt
$515,237
$556,544
$173,730
$2,393,985
$1,037,414
$676,849
$30,456
Long-term debt
$0
$191,525
$494,444
$514,679
$491,722
$0
$468,361
Total liabilities
$515,237
$748,069
$668,174
$2,908,664
$1,529,136
$676,849
$498,817
Other
Headcount
—
7
7
8
7
7
7
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$15.7M
post-money
Healthycell Stock 1
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised $251.8K / $1.1MInvestors 259Post-money $15.7M
Reg CF annual-report compliance
Not requiredFewer than 300 holders of record
Filed 5 of 5 annual reports (FY2021–FY2025)
259 investors
holder-count proxy
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
View all 11 filings on EDGARSource: ManualCIK 0001873475Share price $0.29
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.